Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients …
PJ Hesketh, M Aapro, JC Street, AD Carides - Supportive Care in Cancer, 2010 - Springer
Goals of work Certain patient and treatment characteristics are predictive of chemotherapy-
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients …
PJ Hesketh, M Aapro, JC Street, AD Carides - Supportive Care in Cancer, 2010 - infona.pl
Goals of work Certain patient and treatment characteristics are predictive of chemotherapy-
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients …
PJ Hesketh, M Aapro, JC Street… - Supportive Care in …, 2010 - search.proquest.com
Certain patient and treatment characteristics are predictive of chemotherapy-induced
nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the importance of …
nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the importance of …
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients …
PJ Hesketh, M Aapro, JC Street… - Supportive care in …, 2010 - pubmed.ncbi.nlm.nih.gov
Goals of work Certain patient and treatment characteristics are predictive of chemotherapy-
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients …
PJ Hesketh, M Aapro, JC Street… - Supportive Care in Cancer, 2010 - go.gale.com
Goals of work Certain patient and treatment characteristics are predictive of chemotherapy-
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
[引用][C] Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in …
PJ Hesketh, M Aapro, JC Street… - Supportive Care in Cancer, 2009 - cir.nii.ac.jp
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care
antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving …
antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving …
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients …
PJ Hesketh, M Aapro, JC Street… - Supportive Care in …, 2009 - europepmc.org
Goals of work Certain patient and treatment characteristics are predictive of chemotherapy-
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …
induced nausea and vomiting (CINV). Objectives of this analysis were:(1) confirm the …